Home » Authors » Anette Breindl

Articles by Anette Breindl

Synergistic With Velcade, NPI-0052 Heading To Clinic

Dec. 9, 2005

By Anette Breindl

Synergistic With Velcade, NPI-0052 Heading To Clinic

Dec. 9, 2005

By Anette Breindl

DNA-Methylating Enzyme Set To Become Biotech Workhorse

Dec. 5, 2005

By Anette Breindl

DNA-Methylating Enzyme Set To Become Biotech Workhorse

Dec. 5, 2005

By Anette Breindl

Something Old, Something New In Anxiolytics Research

Nov. 28, 2005

By Anette Breindl

Something Old, Something New In Anxiolytics Research

Nov. 28, 2005

By Anette Breindl

Rats On Cocaine: Examining What Makes Addicts Addicted

Nov. 18, 2005

By Anette Breindl

Rats On Cocaine: Examining What Makes Addicts Addicted

Nov. 18, 2005

By Anette Breindl

Human Channelopathy Project Tackling Epilepsy's Complexity

Nov. 17, 2005

By Anette Breindl

Human Channelopathy Project Tackling Epilepsy's Complexity

Nov. 17, 2005

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 17, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.